Today: 12 May 2026
NVIDIA Corporation Bets $2 Billion on Marvell as Custom AI Chip Race Heats Up
1 April 2026
2 mins read

NVIDIA Corporation Bets $2 Billion on Marvell as Custom AI Chip Race Heats Up

Santa Clara, California — April 1, 2026, 04:08 PDT

Nvidia on Tuesday disclosed a $2 billion investment in Marvell Technology, expanding a partnership that will integrate Marvell’s custom AI chips and networking hardware even more closely with Nvidia’s own systems. Marvell’s stock jumped roughly 7% during the session, and Nvidia added 2.7%.

Nvidia’s latest play underlines its determination to sit at the heart of AI data-center budgets, even as some buyers bypass standard GPUs, shopping for semi-custom chips instead. When it can’t move every chip in the rack, Nvidia aims to supply the interconnects, CPUs, and the surrounding software stack.

Timing comes into play here. This year, heavyweights like Alphabet, Microsoft, Amazon, and Meta plan to pour at least $630 billion into AI infrastructure. Back in March, Broadcom projected AI-chip revenue topping $100 billion in 2027, driven by the surge in custom silicon demand.

Marvell is set to supply custom XPUs—processors designed for targeted workloads—plus networking gear compatible with Nvidia’s NVLink Fusion platform, according to the terms of the agreement. The two firms also plan to collaborate on silicon photonics, a technology that moves data between chips using light, aiming to boost speeds and cut power use.

“The inference inflection has arrived. Token generation demand is surging, and the world is racing to build AI factories,” Chief Executive Jensen Huang said. He added that the companies will help customers “build specialized AI compute.” NVIDIA Newsroom

Marvell CEO Matt Murphy described the expanded partnership as an answer to the growing demand for “high-speed connectivity, optical interconnect and accelerated infrastructure” needed to ramp up AI. According to Murphy, connecting Marvell’s custom silicon and photonics with Nvidia’s ecosystem should make it easier for customers to build systems that scale and run more efficiently. NVIDIA Newsroom

Jacob Bourne, analyst at eMarketer, pointed out that the deal hands Nvidia access to Marvell’s semi-custom silicon and advanced optical interconnects — both crucial, as rising bandwidth demands and power efficiency issues keep tripping up big AI systems. He also noted investors will probably view the partnership as easing some of the roadblocks, since it allows non-Nvidia AI chips to run inside data centers where Nvidia hardware usually dominates.

This partnership lines up with the push Nvidia CEO Jensen Huang made at last month’s GTC, where he leaned further into inference—the point where an AI answers a user’s query—an area where custom processors and CPUs are now going head-to-head with Nvidia’s graphics chips. Notably, Meta also revealed a slate of new homegrown AI chips around then, signaling that heavyweight clients are keen to rein in costs and energy demands.

Still, risks loom. IDC numbers seen by Reuters put Chinese suppliers at about 41% of China’s AI accelerator server market for 2025, with Huawei setting the pace. Nvidia’s share, meanwhile, dropped to 55%—a slide fueled by U.S. export restrictions nudging customers to local alternatives. Nvidia and Marvell have both flagged shifting supply and demand, legal or regulatory moves, and the broader market or political backdrop as potential threats to what their partnership delivers.

Nvidia is sticking to a straightforward bet: even if the AI chip landscape splits up, customers are expected to stick with its platform. By bringing Marvell into the fold, Nvidia tacks on semi-custom chips and optical connectivity—an expansion that joins its existing focus on GPUs, CPUs, networking gear, and software.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

US Stock Market Today: Live Updates 01.04.2026

Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4
Next Story

Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4

Go toTop